Navigation Links
IntegriChain Announces Measurement of Retail Inventory(TM) (MRI) Analytic

New analytic offering provides pharmaceutical manufacturers with a highly reliable measure of inventory levels in the retail channel.

PRINCETON, N.J., April 2 /PRNewswire/ -- US Pharmaceutical manufacturers routinely struggle to accurately quantify the amount of product in the retail channel. This measurement affects a number of key aspects of financial reporting, such as: revenue recognition and returns accrual calculations, SOX compliance, forecasting and other critical financial planning functions. Unfortunately, the pharmaceutical manufacturer has very little visibility to where actual inventory levels are at any specific time. This lack of visibility to retail inventory levels forces pharmaceutical manufacturers to provide "best estimates" or "back of the envelope" calculations which cause significant angst with financial analysts and investors.

Recent industry trends indicate that retail "days on hand" inventories vary dramatically month-to-month and by individual retailer; exposing these critical financial computations to increased levels of potential error. Compounding this problem is the fact that many blockbuster drugs are coming off patent in the next few years, and pharmaceutical manufacturers are looking for ways to more accurately accrue for returns and provide auditable financial reserves for a new economy in the US pharmaceutical market.

Traditionally, most pharmaceutical manufacturers have relied upon doctor prescribing behavior data to determine demand, and have backed into retail inventories from this data. However, a growing number of PBMs are withholding their prescription information from vendors that estimate demand, and an increasing number of states are pursuing legislation to block prescription reporting. As national prescription demand data deteriorates and retail volatility increases, manufacturers' current approach to total pipeline measurement is becoming unsustainable.

IntegriChain, an information service provider to the pharmaceutical industry, has recently announced IntegriChain MRI(TM): Measurement of Retail Inventory; an analytic service which has been specifically designed to provide a highly accurate measurement of retail inventory capable of delivering calculations to +/- 2 days on hand (DOH). The MRI(TM) analytical service is an extension of the company's flagship Enriched Channel Sales(TM) information service which provides a highly accurate (>99%) view into downstream sales of pharmaceutical products into over 300,000 dispensing locations in the US, including all retail pharmacies, mass merchants, hospitals, clinics, long-term care, federal facilities, etc. The company has developed extensive intelligence on retail, wholesale and institution inventory patterns, and through its proprietary analytics provides an unparalleled level of transparency into inventory movement in the downstream market. "We see this as a watershed tool for financial reporting, planning and analysis functions within all US pharmaceutical manufacturers," states Kevin Leininger, chief executive of IntegriChain. "Most pharma companies are left 'in the dark' relative to their total pipeline measures, and we believe our solution offers them a high-confidence measure that they have not had heretofore."

The MRI(TM) service is available on a brand-by-brand basis immediately from IntegriChain and requires a subscription to Enriched Channel Sales(TM). The service is delivered via a standard Microsoft(R) interface and is offered on either monthly or weekly frequency intervals.

About IntegriChain

IntegriChain, Inc. is an information services company which provides data collection, integration, enrichment, analysis and reporting of sales and inventory activity exclusively for the pharmaceutical industry. IntegriChain enables manufacturers to improve sales performance and total pipeline measurement by maximizing transparency and accountability in the down-stream supply chain. IntegriChain's Enriched Channel Sales(TM) and advanced analytics are transforming the role of channel data within key pharmaceutical application areas including new product launch, finance, sales forecasting and demand analysis.

SOURCE IntegriChain, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. IntegriChain Enlists Ed Casey and Associates to Drive Counterfeit and Diversion Monitoring Service
2. Medical Nurse Training, Inc. Announces the Launch of
3. Anesiva Announces Going Concern Opinion and Nasdaq Notice
4. BD Announces Live Webcast of Second Fiscal Quarter Earnings Conference Call
5. Novavax Announces Closing of $11 Million Common Stock Sale to Subsidiary of Cadila Pharmaceuticals
6. HealthSouth Announces Date of 2009 First Quarter Earnings Conference Call
7. Sunesis Pharmaceuticals Announces Up To $43.5 Million Financing
8. Misonix Announces New Distribution Agreement for Belgium and Luxembourg
9. Waters Corporation Announces the Purchase of UPLC/MS Systems by the National Cancer Institute for Advanced Metabolomics Research
10. Harvest Technologies Announces Interim Study Results From Critical Limb Ischemia Trial in Chennai India
11. BPO Management Services Announces Financial Results for Fourth Quarter and Full Year 2008
Post Your Comments:
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a ... can give their videos a whole new perspective by using the title layers ... Film Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/26/2016)... , ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal ... personalized through a fitness app. The fitness app plans to fix the two major problems ... offer a one size fits all type program , They don’t eliminate all ...
(Date:6/25/2016)... ... 25, 2016 , ... Experts from the American Institutes for ... Meeting June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR ... care planning, healthcare costs and patient and family engagement. , AIR researchers will ...
(Date:6/25/2016)... Miami, FL (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton ... Plant City Observer , brings up a new, often overlooked aspect of head lice: ... The closing for fumigation is not a common occurrence, but a necessary one in the ...
(Date:6/25/2016)... ... 25, 2016 , ... First Choice Emergency Room , the largest network ... the Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased ... location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Belgium , June 24, 2016 /PRNewswire/ ... announced the appointment of Dr. Edward Futcher ... a Non-Executive Director, effective June 23, 2016.Dr. Futcher ... and Nominations and Governance Committees.  As a non-executive ... provide independent expertise and strategic counsel to VolitionRx ...
(Date:6/23/2016)... 2016  MedSource announced today that it has ... solution of choice.  This latest decision demonstrates MedSource,s ... their clients by offering a state-of-the-art electronic data ... nowEDC as the EDC platform of choice in ... "nowEDC has long been a preferred EDC platform ...
(Date:6/23/2016)... HILLS, Calif. , June 23, 2016 Any ... the many challenges of the current process. Many of them ... because of the technical difficulties and high laboratory costs involved. ... have to offer it at such a high cost that ... afford it. Dr. Parsa Zadeh , founder ...
Breaking Medicine Technology: